399 related articles for article (PubMed ID: 16274051)
1. [Neoadjuvant therapy in pancreatic cancer].
Ji JF; Li ZY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Oct; 27(5):644-7. PubMed ID: 16274051
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic cancer: current and future treatment strategies.
Pliarchopoulou K; Pectasides D
Cancer Treat Rev; 2009 Aug; 35(5):431-6. PubMed ID: 19328630
[TBL] [Abstract][Full Text] [Related]
3. New frontiers in the neoadjuvant therapy of pancreatic adenocarcinoma: apart from therapeutical protocols.
Berardi R; Verdecchia L; Scartozzi M; Cascinu S
JOP; 2005 Jan; 6(1 Suppl):118-21. PubMed ID: 15650296
[No Abstract] [Full Text] [Related]
4. Therapy of locally advanced pancreatic adenocarcinoma: unresectable and borderline patients.
Kircher SM; Krantz SB; Nimeiri HS; Mulcahy MF; Munshi HG; Benson AB
Expert Rev Anticancer Ther; 2011 Oct; 11(10):1555-65. PubMed ID: 21999129
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant therapy for resectable pancreatic cancer.
Raut CP; Evans DB; Crane CH; Pisters PW; Wolff RA
Surg Oncol Clin N Am; 2004 Oct; 13(4):639-61, ix. PubMed ID: 15350939
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant radiation is associated with improved survival in patients with resectable pancreatic cancer: an analysis of data from the surveillance, epidemiology, and end results (SEER) registry.
Stessin AM; Meyer JE; Sherr DL
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1128-33. PubMed ID: 18538501
[TBL] [Abstract][Full Text] [Related]
7. Effect of different treatment methods on survival in patients with pancreatic cancer.
Brasiūniene B; Juozaityte E; Inciūra A; Brasiūnas V; Barauskas G
Rocz Akad Med Bialymst; 2003; 48():66-9. PubMed ID: 14737944
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant therapy of pancreatic cancer.
Hilbig A; Oettle H
Expert Rev Anticancer Ther; 2010 Apr; 10(4):485-91. PubMed ID: 20397913
[TBL] [Abstract][Full Text] [Related]
9. Multimodality management of localized pancreatic cancer.
Wayne JD; Wolff RA; Pisters PW; Evans DB
Cancer J; 2001; 7 Suppl 1():S35-46. PubMed ID: 11504284
[TBL] [Abstract][Full Text] [Related]
10. Adenocarcinoma of the pancreas: the rationale for neoadjuvant therapy.
Sperti C; Pasquali C; Pastorelli D; Ferronato A; Decet G; Pedrazzoli S
Acta Biomed; 2003; 74 Suppl 2():91-5. PubMed ID: 15055044
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant treatments for resectable pancreatic cancer.
Ueno H; Kosuge T
J Hepatobiliary Pancreat Surg; 2008; 15(5):468-72. PubMed ID: 18836798
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy of neoadjuvant radiochemotherapy in treatment of locally advanced low rectal cancer].
Yu BM; Zhang M; Wu WQ; Chen LW; Fu J; Fei CS; Shen Y
Zhonghua Wai Ke Za Zhi; 2007 Apr; 45(7):445-8. PubMed ID: 17686297
[TBL] [Abstract][Full Text] [Related]
13. [Adjuvant treatment of pancreatic cancer].
Michalski CW; Kleeff J; Jäger D; Friess H; Büchler MW
Dtsch Med Wochenschr; 2007 Apr; 132(15):803-7. PubMed ID: 17427090
[No Abstract] [Full Text] [Related]
14. Effect of neoadjuvant therapy on local recurrence after resection of pancreatic adenocarcinoma.
Greer SE; Pipas JM; Sutton JE; Zaki BI; Tsapakos M; Colacchio TA; Gibson JJ; Wiener DC; Ripple GH; Barth RJ
J Am Coll Surg; 2008 Mar; 206(3):451-7. PubMed ID: 18308215
[TBL] [Abstract][Full Text] [Related]
15. Role of neoadjuvant chemotherapy in rectal cancer: interpretation of the EXPERT study.
Glynne-Jones R; Sebag-Montefiore D
J Clin Oncol; 2006 Oct; 24(28):4664-5; author reply 4665-6. PubMed ID: 17008708
[No Abstract] [Full Text] [Related]
16. Status of neoadjuvant therapy for resectable pancreatic cancer.
Hoffman JP
Surg Oncol Clin N Am; 2010 Apr; 19(2):411-8. PubMed ID: 20159522
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic resections after chemoradiotherapy for locally advanced ductal adenocarcinoma: analysis of perioperative outcome and survival.
Massucco P; Capussotti L; Magnino A; Sperti E; Gatti M; Muratore A; Sgotto E; Gabriele P; Aglietta M
Ann Surg Oncol; 2006 Sep; 13(9):1201-8. PubMed ID: 16955382
[TBL] [Abstract][Full Text] [Related]
18. Histopathological response to preoperative chemoradiation for resectable pancreatic adenocarcinoma: the French Phase II FFCD 9704-SFRO Trial.
Le Scodan R; Mornex F; Partensky C; Mercier C; Valette PJ; Ychou M; Roy P; Scoazec JY
Am J Clin Oncol; 2008 Dec; 31(6):545-52. PubMed ID: 19060585
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic cancer: progress in cancer therapy.
Pierantoni C; Pagliacci A; Scartozzi M; Berardi R; Bianconi M; Cascinu S
Crit Rev Oncol Hematol; 2008 Jul; 67(1):27-38. PubMed ID: 18356073
[TBL] [Abstract][Full Text] [Related]
20. Is there a role for chemoradiotherapy in the treatment of pancreatic carcinoma?
Pasetto LM; Jirillo A; Stefani M; Monfardini S
Anticancer Res; 2003; 23(3C):2805-13. PubMed ID: 12926117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
